**REGISTERED CHARITY NUMBER: 1017576** **Report of the Trustees and** **Unaudited Financial Statements for the Year Ended 31 March 2025** **for** **Cystic Fibrosis Comfort Fund** Monahans Chartered Accountants Lennox House 3 Pierrepont Street Bath Somerset BA1 1LB **Cystic Fibrosis Comfort Fund** ## **Contents of the Financial Statements for the Year Ended 31 March 2025** |||**Page**|| |---|---|---|---| |**Report of the Trustees**||1|| |**Independent Examiner's Report**||2|| |**Statement of Financial Activities**||3|| |**Balance Sheet**||4|| |**Notes to the Financial Statements**|5|to|7| |**Detailed Statement of Financial Activities**||8|| **Cystic Fibrosis Comfort Fund** ## **Report of the Trustees for the Year Ended 31 March 2025** The trustees submit their report for the year ended 31 March 2025. ## **OBJECTIVES AND ACTIVITIES** ## **Objects and Aims of the Charity** To relieve those persons suffering from Cystic Fibrosis and to assist the families of those persons who are in conditions of need, hardship or distress. ## **ACHIEVEMENTS AND PERFORMANCE** ## **Results for the Year** The trustees recorded a surplus of £49,113 for the year (2024: deficit £6,263). ## **FINANCIAL REVIEW** During the year a generous one-off donation of £55,054 was received from the estate of one of our kind donors. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Governing document** The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity. ## **REFERENCE AND ADMINISTRATIVE DETAILS** ## **Registered Charity number** 1017576 ## **Principal address** 17 Filton Avenue Horfield Bristol BS7 0AQ ## **Trustees** K Badlan M Burridge (deceased 25.1.25) K Wedlock K Lindsay J Smith L Nichols T Modzelewski K A Harriman S B Brennan (appointed 12.4.25) ## **Independent Examiner** Robert Branch Monahans Chartered Accountants Lennox House 3 Pierrepont Street Bath Somerset BA1 1LB Approved by order of the board of trustees on ............................................. and signed on its behalf by: ........................................................................ K Badlan - Trustee Page 1 ## **Independent Examiner's Report to the Trustees of Cystic Fibrosis Comfort Fund** ## **Independent examiner's report to the trustees of Cystic Fibrosis Comfort Fund** I report to the charity trustees on my examination of the accounts of Cystic Fibrosis Comfort Fund (the Trust) for the year ended 31 March 2025. ## **Responsibilities and basis of report** As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act'). I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act. ## **Independent examiner's statement** I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Robert Branch Monahans Chartered Accountants Lennox House 3 Pierrepont Street Bath Somerset BA1 1LB Date: ............................................. Page 2 **Cystic Fibrosis Comfort Fund** ## **Statement of Financial Activities for the Year Ended 31 March 2025** |2025
Unrestricted
fund
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
68,467
Investment income
2
1,285
**Total**
69,752
**EXPENDITURE ON**
**Charitable activities**
Support to persons suffering Cystic Fibrosis and
to their families
20,553
Other
86
**Total**
20,639
**NET INCOME/(EXPENDITURE)**
49,113
**RECONCILIATION OF FUNDS**
Total funds brought forward
120,586
**TOTAL FUNDS CARRIED FORWARD**
169,699|2024
Total
funds
£
4,434
1,030
5,464
11,669
58
11,727
(6,263)
126,849
120,586| |---|---| The notes form part of these financial statements Page 3 **Cystic Fibrosis Comfort Fund** ## **Balance Sheet** ## **31 March 2025** |2025
Unrestricted
fund
Notes
£
**CURRENT ASSETS**
Debtors
5
643
Cash at bank
170,152
170,795
**CREDITORS**
Amounts falling due within one year
6
(1,096)
**NET CURRENT ASSETS**
169,699
**TOTAL ASSETS LESS CURRENT LIABILITIES**
169,699
**NET ASSETS**
169,699
**FUNDS**
7
Unrestricted funds
169,699
**TOTAL FUNDS**
169,699|2024
Total
funds
£
675
120,946
121,621
(1,035)
120,586
120,586
120,586
120,586
120,586| |---|---| The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by: ............................................. K Badlan - Trustee The notes form part of these financial statements Page 4 **Cystic Fibrosis Comfort Fund** ## **Notes to the Financial Statements for the Year Ended 31 March 2025** ## **1. ACCOUNTING POLICIES** ## **Basis of preparing the financial statements** The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention. ## **Income** All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. ## **Expenditure** Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. ## **Taxation** The charity is exempt from tax on its charitable activities. ## **Fund accounting** Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. ## **2. INVESTMENT INCOME** |**INVESTMENT INCOME**||| |---|---|---| ||2025|2024| ||£|£| |Investment Income|1,285|1,030| ## **3.** ## **TRUSTEES' REMUNERATION AND BENEFITS** There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024. ## **4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** |**INCOME AND ENDOWMENTS FROM**|Unrestricted
fund
£| |---|---| |Donations and legacies|4,434| |Investment income|1,030| |**Total**|5,464| |**EXPENDITURE ON**|| |**Charitable activities**|| |Support to persons suffering Cystic Fibrosis|| |and to their families|11,669| |Other|58| |**Total**|11,727| Page 5 continued... **Cystic Fibrosis Comfort Fund** ## **Notes to the Financial Statements - continued for the Year Ended 31 March 2025** ## **4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued** |**NET INCOME/(EXPENDITURE)**
**RECONCILIATION OF FUNDS**
Total funds brought forward
**TOTAL FUNDS CARRIED FORWARD**
**5.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Other debtors
**6.**
**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Other creditors
**7.**
**MOVEMENT IN FUNDS**
**Unrestricted funds**
General fund
**TOTAL FUNDS**
Net movement in funds, included in the above are as follows:
**Unrestricted funds**
General fund
**TOTAL FUNDS**
**Comparatives for movement in funds**
**Unrestricted funds**
General fund
**TOTAL FUNDS**|At 1.4.24
£
120,586
120,586
Incoming
resources
£
69,752
69,752
At 1.4.23
£
126,849
126,849|Unrestricted
fund
£
(6,263)
126,849
120,586
2025
2024
£
£
643
675
2025
2024
£
£
1,096
1,035
Net
movement
At
in funds
31.3.25
£
£
49,113
169,699
49,113
169,699
Resources
Movement
expended
in funds
£
£
(20,639)
49,113
(20,639)
49,113
Net
movement
At
in funds
31.3.24
£
£
(6,263)
120,586
(6,263)
120,586| |---|---|---| Page 6 continued... **Cystic Fibrosis Comfort Fund** ## **Notes to the Financial Statements - continued for the Year Ended 31 March 2025** ## **7. MOVEMENT IN FUNDS - continued** Comparative net movement in funds, included in the above are as follows: |Incoming
resources
£
**Unrestricted funds**
General fund
5,464
**TOTAL FUNDS**
5,464
A current year 12 months and prior year 12 months combined position is as follows:
At 1.4.23
£
**Unrestricted funds**
General fund
126,849
**TOTAL FUNDS**
126,849|Resources
Movement
expended
in funds
£
£
(11,727)
(6,263)
(11,727)
(6,263)

Net
movement
At
in funds
31.3.25
£
£
42,850
169,699
42,850
169,699| |---|---| A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |**Unrestricted funds**|Incoming
Resources
resources
expended
£
£|Movement
in funds
£| |---|---|---| |General fund|75,216
(32,366)|42,850| |**TOTAL FUNDS**|75,216
(32,366)|42,850| ## **8. RELATED PARTY DISCLOSURES** There were no related party transactions for the year ended 31 March 2025. Page 7 **Cystic Fibrosis Comfort Fund** ## **Detailed Statement of Financial Activities for the Year Ended 31 March 2025** ||2025|2024| |---|---|---| ||£|£| |**INCOME AND ENDOWMENTS**||| |**Donations and legacies**||| |Gifts and Donations|13,413|4,434| |Legacies|55,054|-| |**Investment income**|68,467|4,434| |Investment Income|1,285|1,030| |**Total incoming resources**|69,752|5,464| |**EXPENDITURE**||| |**Charitable activities**||| |Advertising|501|-| |Support to persons suffering Cystic Fibrosis and||| |to their families|8,687|6,502| |Grants to individuals|8,000|3,250| |**Support costs**|17,188|9,752| |**Management**||| |Telephone|314|415| |Postage and stationery|424|396| |Sundries|-|80| |Conference & Travel costs|1,840|40| |Website costs|71|300| |**Finance**|2,649|1,231| |Bank charges|15|15| |JustGiving charges|216|216| |**Governance costs**|231|231| |Accountancy and legal fees|571|513| |Total resources expended|20,639|11,727| |**Net income/(expenditure)**|49,113|(6,263)| This page does not form part of the statutory financial statements Page 8